alexa Role Of Pharmacovigilance In Off-label Drug Use
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Imran Maniyar
Posters: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.014
Abstract
The new definition of Adverse Drug Reaction (ADR) laid by 2012 Pharmacovigilance (PV) legislation has included a wide range of drug related effects importantly off-label use, misuse and abuse of medications. According to Good Pharmacovigilance Practice (GVP), Off-label use is defined as ?situations where a medicinal product is intentionally used for a medical purpose not in accordance with the authorised product information?. The FDA regulations allow doctors to prescribe drugs for off-label use, but pharmaceutical industries holds no right to promote such uses. If physicians want to use a medicinal product for an indication beyond the authorised product information, they hold the responsibility to be well informed about the product, to base its use on firm scientific basis and on evidence based medicine, and product?s use and effects should be documented. Also the off-label use of medicinal product doesn?t require submission for an Investigational New Drug Application (IND), Investigational Device Exemption (IDE) or review by an Institutional Review Board (IRB). But Off label medicines are more likely to be associated in an ADR than authorised medicines. Indian PV system for off-label use is still not well developed, even after implementation of Pharmacovigilance programme of India (PvPI) based on the recommendations of WHO laid by CDSCO; still the rate of ADR reporting for off-label use is below par and there have not been any conclusive studies which gives the present status of rate and extent of ADR reporting for off-label use in India. The objective here is to give an Overview of Off-label drug use in India and the role of Pharmacovigilance for ADR reporting related to Off-label use.
Biography
Imran Maniyar has completed his MBBS from Yenepoya Medical College, Mangalore and is now pursuing his PG In Pharmacology in JJM Medical Davangere. At present he is involved in two research paper.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engin[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version